ERYTECH proposes the appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors

  • Post author:
  • Post category:Newsroom

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, is announcing that the Board of Directors will propose the appointment of Jean-Paul Kress as a Director at the Annual General Meeting on June 21, 2019, with a view to appointing him as Chairman of the Board of Directors. Dr. Kress possesses over 25 years’ experience as a senior executive in international biotech and pharma groups.

Menu